Bromocriptine Capsules and Insulin Degludec (U-200) Prefilled Pens
Determining the interaction of Bromocriptine Capsules and Insulin Degludec (U-200) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Capsules-Insulin degludec and liraglutide
- Bromocriptine Capsules-Insulin degludec and liraglutide Subcutaneous
- Bromocriptine Capsules-Insulin degludec Subcutaneous
- Bromocriptine Capsules-Insulin detemir
- Bromocriptine Capsules-Insulin Detemir (Cartridges and Prefilled Syringes)
- Bromocriptine Capsules-Insulin Detemir (Vials)
- Insulin Degludec (U-200) Prefilled Pens-Bromocriptine Mesylate
- Insulin Degludec (U-200) Prefilled Pens-Brompheniramine
- Insulin Degludec (U-200) Prefilled Pens-Brompheniramine and codeine
- Insulin Degludec (U-200) Prefilled Pens-Brompheniramine and phenylephrine
- Insulin Degludec (U-200) Prefilled Pens-Brompheniramine and Phenylephrine Chewable Tablets
- Insulin Degludec (U-200) Prefilled Pens-Brompheniramine and Phenylephrine Liquid